Ignite Creation Date:
2024-05-06 @ 10:06 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03168100
Status:
WITHDRAWN
Last Update Posted:
2019-01-28
First Post:
2017-05-24
Brief Title:
2017-03 A Single-Arm Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 Anti-SLAMF7 Monoclonal Antibody mAb Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma
Sponsor:
Organization:
University of Arkansas
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
0
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: